Adams Diversified Equity Fund’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-128,057
Closed -$14.5M 104
2024
Q2
$14.5M Sell
128,057
-66,900
-34% -$8.46M 0.5% 71
2024
Q1
$27M Hold
194,957
0.96% 35
2023
Q4
$24.2M Hold
194,957
0.95% 42
2023
Q3
$18.2M Hold
194,957
0.78% 54
2023
Q2
$25.1M Hold
194,957
1.04% 29
2023
Q1
$22.7M Buy
+194,957
New +$21.8M 1.02% 31

Other funds holding DXCM

Adams Diversified Equity Fund's DXCM Position: Q3 2024 in Review

Adams Diversified Equity Fund sold out of DexCom (DXCM) in Q3 2024, closing a stake of 128,057 shares — an estimated $14.5M sold.

Adams Diversified Equity Fund first reported a position in DXCM in Q1 2023 and held it in 6 quarters. The position peaked at $27M in Q1 2024. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Adams Diversified Equity Fund reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Adams Diversified Equity Fund sold 128,057 DexCom shares in Q3 2024, an estimated $14.5M.
  • Adams Diversified Equity Fund first reported a position in DexCom in Q1 2023 and held it in 6 quarters.
  • Adams Diversified Equity Fund's DexCom position peaked at $27M in Q1 2024.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Adams Diversified Equity Fund's 13F filing for Q3 2024, filed 25 Oct 2024.